认知正常老年人脑淀粉样蛋白与焦虑抑郁症状的纵向关联
研究纳入270名社区居住的认知正常老年人,基线行PiB PET测皮质淀粉样蛋白,并每年用30项老年抑郁量表评估,平均随访3.8年。混合效应模型显示,较高PiB结合预测GDS总分及焦虑-注意力集中评分随时间加速上升,且校正抑郁史后仍显著。提示淀粉样蛋白负荷与焦虑抑郁症状加重相关,支持神经精神症状可能是临床前阿尔茨海默病的早期表现。
要点
- 较高脑淀粉样蛋白负荷预测认知正常老年人GDS总分随时间加速上升。
- PiB结合亦预测焦虑-注意力集中评分加速上升,校正抑郁史和AMNART后显著。
- 既往抑郁史与较高但非加重的症状评分相关。
核心结论
- 较高淀粉样蛋白负荷与认知正常老年人焦虑抑郁症状随时间加重相关,支持神经精神症状可能是临床前阿尔茨海默病的早期表现。
研究设计与样本
- 研究为纵向队列分析,纳入270名社区居住、认知正常的老年人,基线行PiB PET测皮质淀粉样蛋白,并每年用30项老年抑郁量表评估,平均随访3.8年(范围1-5年)。
主要发现
- 校正抑郁史后,较高PiB结合预测GDS总分随时间加速上升。
- 校正抑郁史和AMNART-by-time交互后,较高PiB结合预测焦虑-注意力集中评分加速上升。
- 事后模型去除注意力集中障碍条目后,PiB结合-by-time交互仍显著。
- 既往抑郁史与较高但非加重的症状评分相关。
关键数值与推荐
- PiB结合作为连续变量预测GDS总分及三个条目簇(淡漠-快感缺失、烦躁、焦虑-注意力集中)的均值评分。
- 混合效应模型采用后向剔除,初始预测因子包括PiB结合、年龄、性别、Hollingshead评分、AMNART评分、APOE ε4状态、抑郁史及其与时间的交互。
临床怎么用
- 在认知正常老年人中,较高淀粉样蛋白负荷提示需关注焦虑抑郁症状的纵向加重。
- 既往抑郁史与较高症状评分相关,但未预测症状加重。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To understand the role of depressive symptoms in preclinical Alzheimer's disease, it is essential to define their temporal relationship to Alzheimer's proteinopathies in cognitively normal older adults. The study objective was to examine associations of brain amyloid beta and longitudinal measures of depression and depressive symptom clusters in a cognitively normal sample of older adults. METHOD: A total of 270 community-dwelling, cognitively normal elderly individuals underwent baseline Pittsburgh compound B (PiB) positron emission tomography (PET) measures of cortical aggregate amyloid beta and annual assessments with the 30-item Geriatric Depression Scale (GDS). The authors evaluated continuous PiB binding as a predictor of GDS score or GDS cluster, calculated as total scores and mean scores for three GDS item clusters (apathy-anhedonia, dysphoria, and anxiety-concentration), across time (1-5 years; mean=3.8 years) in separate mixed-effects models with backward elimination. Initial predictors included PiB binding, age, sex, Hollingshead score, American National Adult Reading Test (AMNART) score, apolipoprotein E ε4 status, depression history, and their interactions with time. RESULTS: Higher PiB binding predicted accelerated rates of increase in GDS score over time, adjusting for depression history. Higher PiB binding also predicted steeper rates of increase for anxiety-concentration scores, adjusting for depression history and the AMNART score-by-time interaction. In a post hoc model estimating anxiety scores without concentration disturbance items, the PiB binding-by-time interaction remained significant. CONCLUSIONS: Higher amyloid beta burden was associated with increasing anxious-depressive symptoms over time in cognitively normal older individuals. Prior depression history was related to higher but not worsening symptom ratings. These results suggest a direct or indirect association of elevated amyloid beta levels with worsening anxious-depressive symptoms and support the hypothesis that emerging neuropsychiatric symptoms represent an early manifestation of preclinical Alzheimer's disease.
引用
- Donovan NJ, Locascio JJ, Marshall GA, et al. Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry. 2018. PMID: 29325447. doi:10.1176/appi.ajp.2017.17040442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。